ChAdOx2 HAV, MVA HAV clinical trials

A study to investigate whether novel vaccines can improve Crohn's disease by targeting a bacterium thought to contribute to the condition

This study is testing two new vaccines for Crohn's disease. Researchers believe these vaccines could help by targeting a specific common bacterium. It's a Phase II trial looking at how well they work, their safety, and how the body reacts in adults with active Crohn's.